Latest Breaking News On - Consilium strategic communications - Page 2 : comparemela.com

Investegate | Company Announcement

Investegate announcements from Block Listing Interim Review

IBA finalizes contract with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel

Louvain-La-Neuve, Belgium, September 27, 2023 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed the final contract with Medtechnica Ltd for the installation of two Proteus®ONE1compact proton therapy solutions at the Sourasky Medical Center (Ichilov Hospital) in Tel Aviv, Israel. This follows the signature of a binding term sheet p

Sitryx Therapeutics: Sitryx raises additional $39 million to progress development of disease-modifying therapeutics for chronic autoimmune and inflammatory disease

NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy

Genomic Vision Attended the 20th Edition of the European Drug Discovery Innovation Programme in Barc

The event highlighted the rising importance of artificial intelligence (AI) and machine learning (ML) in drug discovery.Genomic Vision actively engaged in networking, fostering new customers interested in GV technology and its applications in general.Genomic Vision's Replication Combing Assay (RCA) aligns with evolv.